Results 171 to 180 of about 5,574 (244)

Creating A Multi-Criteria Decision Analysis Tool to Enhance Value-Based Purchasing of Generic and Biosimilar Medications in Saudi Arabia: A Pilot Study. [PDF]

Clinicoecon Outcomes Res
Alruthia Y, Alhajri H, Almohammed OA, Balkhi B, Alsaqa'aby MF, Almuqbil MA, Al-Abdulkarim HA, Almutairi AR.   +7 more
europepmc   +1 more source

An analysis of cost-saving in the German statutory health insurance system due to the introduction of epoetin alfa biosimilars in Germany. [PDF]

Front Public Health
Raitner I, Müller B, Vijayan A, Zimmermann L, Bramlage P, Ness NH, Müller M.   +6 more
europepmc   +1 more source

Out-of-Pocket Spending for Biologic Drugs After Biosimilar Competition for Medicare Patients.

JAMA Netw Open
Riegler JS, Kesselheim AS, Rome BN.
europepmc   +1 more source

Comparative outcomes of aflibercept biosimilars and reference aflibercept in nAMD: a systematic review and meta-analysis. [PDF]

BMJ Open Ophthalmol
Sawires K, Nithianandan H, Somani S.
europepmc   +1 more source

​Did a Non-Medical Biosimilar Switching Policy Cause an Increase in Non-Biologic/Biosimilar Health Care Resource Utilization or Cost in Patients With Inflammatory Arthritis? [PDF]

Arthritis Care Res (Hoboken)
Dang H, Blitz S, Bansback N, Law M, Harrison M.   +4 more
europepmc   +1 more source

Real-World Efficacy and Safety of Adalimumab Biosimilar (HS016) in Biologic-Naïve Patients with Perianal Fistulizing Crohn's Disease: A Prospective, Single-Arm, Observational Study. [PDF]

Drug Des Devel Ther
Yu Q, Cheng Y, Wang H, Fang L, Chen Y, Zhang X, Li J, Fu X, Li J, Zhu L.   +9 more
europepmc   +1 more source

Efficacy and safety of sintilimab plus a bevacizumab biosimilar combined with transarterial chemoembolization for advanced hepatocellular carcinoma. [PDF]

Medicine (Baltimore)
Yang J, Xu Q, Wu S.
europepmc   +1 more source

Real-world outcomes of ranibizumab biosimilars in various retinal diseases: a Korean multi-center experience-ROSE Korea Study. [PDF]

Sci Rep
Song JR, Park UC, Lee CS, Cho JJ, Kim JY, Baek SC, Jeong A, Sharma A, Kim JH, Sagong M, Woo SJ, International Retina Biosimilar Study Group (Inter BIOS Group).   +11 more
europepmc   +1 more source

Regulierung und adäquate Preisbildung im Markt der Biosimilars: Projekt im Auftrag der Pfizer Deutschland GmbH

, 2017
Altin, Sibel, Bauer, Cosima, May, Uwe, Walendzik, Anke, Wasem, Jürgen, Ziebe, Anissa   +5 more
core  

Production of a Dulaglutide Analogue by Apoptosis-Resistant Chinese Hamster Ovary Cells in a 3-Week Fed-Batch Process. [PDF]

Pharmaceuticals (Basel)
Shaifutdinov RR, Sinegubova MV, Vorobiev II, Prokhorova PE, Podkorytov AB, Orlova NA.   +5 more
europepmc   +1 more source